Last reviewed · How we verify

Neomycin and Flagyl

Ottawa Hospital Research Institute · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Neomycin and Flagyl is a Small molecule drug developed by Ottawa Hospital Research Institute. It is currently FDA-approved. Also known as: Metronidazole.

Neomycin is a small molecule antibiotic used in fecal microbiota transplantation for conditions such as metastatic colorectal adenocarcinoma and stage IV colorectal cancer. Flagyl, also known as metronidazole, is not mentioned in the provided facts, but Neomycin is used in combination with other interventions like fecal microbiota transplantation for the mentioned conditions.

At a glance

Generic nameNeomycin and Flagyl
Also known asMetronidazole
SponsorOttawa Hospital Research Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Neomycin and Flagyl

What is Neomycin and Flagyl?

Neomycin and Flagyl is a Small molecule drug developed by Ottawa Hospital Research Institute.

Who makes Neomycin and Flagyl?

Neomycin and Flagyl is developed and marketed by Ottawa Hospital Research Institute (see full Ottawa Hospital Research Institute pipeline at /company/ottawa-hospital-research-institute).

Is Neomycin and Flagyl also known as anything else?

Neomycin and Flagyl is also known as Metronidazole.

What development phase is Neomycin and Flagyl in?

Neomycin and Flagyl is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing